NasdaqGS - Nasdaq Real Time Price USD
Voyager Therapeutics, Inc. (VYGR)
3.4900
+0.1200
+(3.56%)
At close: April 23 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 418,250 | 6 |
| Sales | 84,015 | 12 |
| Net Shares Purchased (Sold) | 334,235 | 18 |
| Total Insider Shares Held | 9.48M | -- |
| % Net Shares Purchased (Sold) | 3.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SANDROCK ALFRED W JR Chief Executive Officer | Sale at price 3.43 per share. | Direct | 37,336 | Apr 2, 2025 |
| FERGUSON TOBY Officer | Sale at price 3.43 per share. | Direct | 34,595 | Apr 2, 2025 |
| SANDROCK ALFRED W JR Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 21, 2025 |
| JORGENSEN NATHAN D. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 21, 2025 |
| SWARTZ ROBIN Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 21, 2025 |
| CARTER TODD ALFRED Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 21, 2025 |
| FAHEY SANDELL JACQUELYN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 21, 2025 |
| FERGUSON TOBY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 21, 2025 |
| SANDROCK ALFRED W JR Chief Executive Officer | Sale at price 4.24 per share. | Direct | 49,616 | Feb 20, 2025 |
| SWARTZ ROBIN Chief Operating Officer | Sale at price 4.25 per share. | Direct | 16,550 | Feb 20, 2025 |
| CARTER TODD ALFRED Officer | Sale at price 4.26 per share. | Direct | 14,079 | Feb 20, 2025 |
| SANDROCK ALFRED W JR Chief Executive Officer | Sale at price 4.45 per share. | Direct | 74,066 | Feb 11, 2025 |
| SWARTZ ROBIN Chief Operating Officer | Sale at price 4.45 per share. | Direct | 30,928 | Feb 11, 2025 |
| CARTER TODD ALFRED Officer | Sale at price 4.45 per share. | Direct | 24,088 | Feb 11, 2025 |
| FAHEY SANDELL JACQUELYN Officer | Sale at price 4.45 per share. | Direct | 19,393 | Feb 11, 2025 |
| SWARTZ ROBIN Chief Operating Officer | Sale at price 5.09 per share. | Direct | 15,713 | Jan 14, 2025 |
| CARTER TODD ALFRED Officer | Sale at price 5.13 per share. | Direct | 6,110 | Jan 14, 2025 |
| SWARTZ ROBIN Chief Operating Officer | Sale at price 5.65 per share. | Direct | 36,725 | Dec 23, 2024 |
| FAHEY SANDELL JACQUELYN Officer | Sale at price 5.82 per share. | Direct | 34,914 | Oct 2, 2024 |
| JORGENSEN NATHAN D. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 1, 2024 |
| SANDROCK ALFRED W JR Chief Executive Officer | Sale at price 9.86 per share. | Direct | 119,454 | Apr 2, 2024 |
| SWARTZ ROBIN Chief Operating Officer | Sale at price 9.88 per share. | Direct | 13,407 | Apr 2, 2024 |
| FERGUSON TOBY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2024 |
| SANDROCK ALFRED W JR Chief Executive Officer | Sale at price 7.46 per share. | Direct | 97,226 | Feb 21, 2024 |
| PFREUNDSCHUH PETER P Chief Financial Officer | Sale at price 7.46 per share. | Direct | 28,079 | Feb 21, 2024 |
| SWARTZ ROBIN Chief Operating Officer | Sale at price 7.45 per share. | Direct | 29,547 | Feb 21, 2024 |
| CARTER TODD ALFRED Officer | Sale at price 7.47 - 7.68 per share. | Direct | 29,760 | Feb 21, 2024 |
| SANDROCK ALFRED W JR Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 9, 2024 |
| PFREUNDSCHUH PETER P Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 9, 2024 |
| SWARTZ ROBIN Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 9, 2024 |
| CARTER TODD ALFRED Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 9, 2024 |
| FAHEY SANDELL JACQUELYN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 9, 2024 |
| SWARTZ ROBIN Chief Operating Officer | Sale at price 7.15 per share. | Direct | 18,182 | Jan 17, 2024 |
| CARTER TODD ALFRED Officer | Sale at price 7.18 per share. | Direct | 9,090 | Jan 17, 2024 |
| PFREUNDSCHUH PETER P Chief Financial Officer | Sale at price 6.99 per share. | Direct | 94,833 | Oct 3, 2023 |
| FAHEY SANDELL JACQUELYN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 29, 2023 |
| CARTER TODD ALFRED Officer | Sale at price 8.16 per share. | Direct | 85,680 | Sep 15, 2023 |
| CARTER TODD ALFRED Officer | Conversion of Exercise of derivative security at price 2.85 per share. | Direct | 14,250 | Sep 15, 2023 |
| CARTER TODD ALFRED Officer | Sale at price 10.80 per share. | Direct | 59,400 | Jul 6, 2023 |
| CARTER TODD ALFRED Officer | Sale at price 11.41 per share. | Direct | 57,050 | Jun 30, 2023 |
| CARTER TODD ALFRED Officer | Conversion of Exercise of derivative security at price 2.85 per share. | Direct | 14,250 | Jun 30, 2023 |
| SANDROCK ALFRED W JR Chief Executive Officer | Sale at price 7.83 per share. | Direct | 58,232 | Apr 3, 2023 |
| SWARTZ ROBIN Chief Operating Officer | Sale at price 7.83 per share. | Direct | 9,858 | Apr 3, 2023 |
| HESSLEIN ROBERT W General Counsel | Sale at price 7.76 per share. | Direct | 34,222 | Mar 20, 2023 |
| SWARTZ ROBIN Chief Operating Officer | Sale at price 7.76 per share. | Direct | 28,355 | Mar 20, 2023 |
| CARTER TODD ALFRED Officer | Sale at price 7.76 per share. | Direct | 17,018 | Mar 20, 2023 |
| SWARTZ ROBIN Chief Operating Officer | Sale at price 8.20 per share. | Direct | 126,059 | Mar 15, 2023 |
| NEUROCRINE BIOSCIENCE INC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.92 per share. | Direct | 30,417,469 | Feb 23, 2023 |
| SANDROCK ALFRED W JR Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 17, 2023 |
| PFREUNDSCHUH PETER P Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 17, 2023 |
Related Tickers
BPMC Blueprint Medicines Corporation
85.81
+2.88%
RGNX REGENXBIO Inc.
8.87
+13.43%
PTCT PTC Therapeutics, Inc.
49.95
+3.65%
ADVM Adverum Biotechnologies, Inc.
2.8500
-3.72%
ALEC Alector, Inc.
1.1600
+4.50%
CTMX CytomX Therapeutics, Inc.
0.7302
-0.80%
AGIO Agios Pharmaceuticals, Inc.
28.37
+1.32%
REPL Replimune Group, Inc.
8.83
+1.38%
WVE Wave Life Sciences Ltd.
6.79
+3.51%
RARE Ultragenyx Pharmaceutical Inc.
37.31
+3.90%